Deuterium-enriched fingolimod
作者： Anthony W. Czarnik
DOI:
关键词:
摘要: The present application describes deuterium-enriched fingolimod, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
lens.org 参考文章(7)
Ehud Keinan, Avidor Shulman, Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds ,(1998)
Thomas G. Gant, Sepehr Sarshar, Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties ,(2006)
Kazuo Ando, Kiyoshi Kawamura, Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents ,(2000)
Hironao Sajiki, Kazushige Muto, Tsuneaki Maesawa, Kosaku Hirota, Nobuhiro Ito, Method for deuteration of a heterocyclic ring ,(2003)
Kanth V. B. Josyula, Christopher Dudley Hewitt, Peng Gao, Robert Todd, Mark C. Potyen, Stabilized deuteroborane-tetrahydrofuran complex ,(2007)
Richard Lewanczuk, Gilles Caille, Robert T. Foster, Method of using deuterated calcium channel blockers ,(2001)
Shigeo Sasaki, Masahiko Yoneta, Tetsuro Fujita, Tadashi Yoshitomi Pharmac. Ind. Ltd. Mishina, Kunitomo Yoshitomi Pharmac. Ind. Ltd. Adachi, Kenji Yoshitomi Pharmac. Ind. Ltd Chiba, 2-amino-1,3-propanediol compound and immunosuppressant ,(1993)